Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$0.6983
-0.09-11.90%
At close: -
$0.7332
0.035.00%
After Hours: Apr 4, 4:09 PM EDT
Comments
Loading...
Werewolf Therapeutics Stock Price, Quotes and Forecasts
HOWLNASDAQ
Werewolf Therapeutics (HOWL) Forecast
NewsEarningsWerewolf Therapeutics (HOWL) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Werewolf Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:HOWL | Benzinga
Explore Werewolf Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for HOWL.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Werewolf Therapeutics (HOWL) stock?
You can purchase shares of Werewolf Therapeutics (NASDAQ:HOWL) through any online brokerage.
Who are Werewolf Therapeutics (HOWL) competitors?
Other companies in Werewolf Therapeutics’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Kezar Life Sciences (NASDAQ:KZR), Estrella Immunopharma (NASDAQ:ESLA), Connect Biopharma Hldgs (NASDAQ:CNTB) and Coeptis Therapeutics (NASDAQ:COEP).
What is the forecast, or price target, for Werewolf Therapeutics (HOWL) stock?
Werewolf Therapeutics has a consensus price target of $10.38.
What is the current price for Werewolf Therapeutics (HOWL)?
The stock price for Werewolf Therapeutics (NASDAQ: HOWL) is $0.7332 last updated April 4, 2025 at 4:09 PM EDT.
Does Werewolf Therapeutics (HOWL) pay a dividend?
There are no upcoming dividends for Werewolf Therapeutics.
When is Werewolf Therapeutics (NASDAQ:HOWL) reporting earnings?
Werewolf Therapeutics’s Q1 earnings are confirmed for Friday, May 2, 2025.
Is Werewolf Therapeutics (HOWL) going to split?
There is no upcoming split for Werewolf Therapeutics.
What sector and industry does Werewolf Therapeutics (HOWL) operate in?
Werewolf Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.